Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Commentary

Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?

Filip Van den Bosch*, Filip De Keyser, Herman Mielants and Eric M Veys

Arthritis Research & Therapy 2005, 7:121-123  doi:10.1186/ar1742

Article Metrics

2576
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 40 accesses
  • Last 365 days: 297 accesses
  • All time: 2576 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information